Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DTaP-poliomyelitis combined vaccine
- Development stage
- Preclinical
- Lead developer
- Beijing Institute of Biological Products
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
DTaP-poliomyelitis combined vaccine (also known as adsorbed DTaP-poliomyelitis combined vaccine or DTaP-IPV) is a combination vaccine being developed by the Beijing Institute of Biological Products (a subsidiary of China National Biotec Group and Sinopharm). It is designed to provide active immunization against diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis (polio) in infants and children. The vaccine is formulated with diphtheria toxoid, tetanus toxoid, acellular pertussis antigens (such as pertussis toxoid, filamentous hemagglutinin, and pertactin), and inactivated poliovirus types 1, 2, and 3, adsorbed onto an aluminum-based adjuvant to enhance immunogenicity. It is currently in clinical development in China.
- Other names
- Adsorbed DTaP-poliomyelitis combined vaccineDTaP-IPVDTaP-polio combination vaccineDTaP-poliomyelitis vaccine
02
Targets
Diphtheria toxinFHA (Filamentous hemagglutinin)PRN (Pertactin)
Beyond the preview
Go deeper on DTaP-poliomyelitis combined vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DTaP-poliomyelitis combined vaccine.